AU572364B2 - 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field - Google Patents

4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field

Info

Publication number
AU572364B2
AU572364B2 AU49971/85A AU4997185A AU572364B2 AU 572364 B2 AU572364 B2 AU 572364B2 AU 49971/85 A AU49971/85 A AU 49971/85A AU 4997185 A AU4997185 A AU 4997185A AU 572364 B2 AU572364 B2 AU 572364B2
Authority
AU
Australia
Prior art keywords
imidazole
methyl
sedative
dimethylbenzyl
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU49971/85A
Other languages
English (en)
Other versions
AU4997185A (en
Inventor
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaha-Vahe
Outi Marilta Vainio-Kivinen
Raimo Einari Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmos Yhtyma Oy
Original Assignee
Farmos Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Yhtyma Oy filed Critical Farmos Yhtyma Oy
Publication of AU4997185A publication Critical patent/AU4997185A/en
Application granted granted Critical
Publication of AU572364B2 publication Critical patent/AU572364B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Stringed Musical Instruments (AREA)
AU49971/85A 1984-12-04 1985-11-15 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field Expired AU572364B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI844786 1984-12-04
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.

Publications (2)

Publication Number Publication Date
AU4997185A AU4997185A (en) 1986-06-12
AU572364B2 true AU572364B2 (en) 1988-05-05

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49971/85A Expired AU572364B2 (en) 1984-12-04 1985-11-15 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field

Country Status (11)

Country Link
US (1) US4670455A (https=)
EP (1) EP0187471B1 (https=)
JP (1) JPS61134314A (https=)
AT (1) ATE65694T1 (https=)
AU (1) AU572364B2 (https=)
DE (1) DE3583670D1 (https=)
DK (1) DK163960C (https=)
FI (1) FI844786A0 (https=)
IE (1) IE58269B1 (https=)
NZ (1) NZ213604A (https=)
ZA (1) ZA858416B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
BR112016006848A2 (pt) 2013-10-07 2017-08-01 Teikoku Pharma Usa Inc métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
CA2924233C (en) 2013-10-07 2018-10-23 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
TWI764951B (zh) 2016-10-31 2022-05-21 美商帝國製藥美國股份有限公司 用於處理疼痛之右美托咪啶經皮遞送裝置
KR102793584B1 (ko) 2016-12-31 2025-04-09 바이오엑셀 테라퓨틱스 인코포레이티드 불안의 치료를 위한 설하 덱스메데토미딘의 용도
PL3813802T3 (pl) 2018-06-27 2025-04-22 Bioxcel Therapeutics, Inc. Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
EP3999058A4 (en) 2019-07-19 2023-05-03 Bioxcel Therapeutics, Inc. NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8223082A (en) * 1981-04-22 1982-10-28 Farmos-Yhtyma Oy 2-phenyl-imidazole an imidazoline derivatives
AU552322B2 (en) * 1981-02-05 1986-05-29 Farmos-Yhtyma Oy Substituted imidazoles
AU566014B2 (en) * 1982-08-14 1987-10-08 Wellcome Foundation Limited, The Imidazole derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU552322B2 (en) * 1981-02-05 1986-05-29 Farmos-Yhtyma Oy Substituted imidazoles
AU8223082A (en) * 1981-04-22 1982-10-28 Farmos-Yhtyma Oy 2-phenyl-imidazole an imidazoline derivatives
AU566014B2 (en) * 1982-08-14 1987-10-08 Wellcome Foundation Limited, The Imidazole derivatives

Also Published As

Publication number Publication date
IE58269B1 (en) 1993-08-25
ZA858416B (en) 1986-07-30
US4670455A (en) 1987-06-02
ATE65694T1 (de) 1991-08-15
DK163960B (da) 1992-04-27
JPS61134314A (ja) 1986-06-21
IE853024L (en) 1986-06-04
DK163960C (da) 1992-09-21
FI844786A0 (fi) 1984-12-04
AU4997185A (en) 1986-06-12
DE3583670D1 (de) 1991-09-05
EP0187471A3 (en) 1988-09-14
NZ213604A (en) 1988-09-29
JPH0465050B2 (https=) 1992-10-16
EP0187471B1 (en) 1991-07-31
EP0187471A2 (en) 1986-07-16
DK508985D0 (da) 1985-11-05
DK508985A (da) 1986-06-05

Similar Documents

Publication Publication Date Title
AU572364B2 (en) 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
AU591740B2 (en) 2-((3,5-dihalo-4-aminobenzyl)) imidazolines
CA2149462A1 (en) Telecommunications feature server
AU540613B2 (en) Anti inflamatory 4,5-diaryl-2(substituted - thio)pyrroles
AU555880B2 (en) N-substituted 1,2,4 triosoles and imidazoles
AU563921B2 (en) 1-(1,3-dioxolan-2-ylmethyl)azole derivatives
AU587995B2 (en) 1-substituted tetralin derivatives, their preparation and their use
AU585214B2 (en) Imidazole and 1,2,4-triazole derivatives
AU568997B2 (en) Substituted 5-(1,4-piperazinyl)-2,4-diaminopyridine
AU7383191A (en) Novel retinoids
AU8111282A (en) 1,2,3,6 tetrahydropyridines as anorectic agents
AU8174482A (en) 1-(1,2,4-triazol-1-yl)-2-cyano-ethanes
AU574532B2 (en) N,n1 - disubstituted imidazoles useful as hypoglycemic agents
AU579514B2 (en) Fungicidal imidazole and 1,2,4-triazole derivatives
AU2580984A (en) Substituted 6,7-dihydro-benzo(i,j)quinolizines
AU564868B2 (en) Mono-tertiary alkylated tolufne diamine
AU6414286A (en) 1,2,5-substituted imidazole compounds
AU5060979A (en) 1-n,n-dimethylcarbamoyl-3(5)-alkyl-5(3)-alkylthioalkylthio- 1,2,4-triazoles
AU3806285A (en) Hydantoin derivatives, process for producing the same and medicine containing the same.
AU4947985A (en) Herbicidal composition comprising 2-(4-chloro-2-fluoro-5-n-pentyloxycarbonylmethoxyphenyl) -4,5,6,7-tetrahydro-2h-isoindole-1,3-dione
AU7334487A (en) Phenyl substituted 1,2,4-triazole derivatives
AU9074582A (en) 1-(3,4,5-trimethoxycinnamoyl)-4-aminocarbonylethyl- piperazine derivatives
AU8750782A (en) 1-(trihalomethyl-sulfenyl)-4-aryl-1,2,4-triazolidin-5- ones and fungici-des containing same
CA2250844A1 (en) Anti-hiv composition comprising imidazole derivatives